approved_drugs

Track hit to lead campaigns of all approved small molecules

List

2019

alpelisib (Piqray; Novartis)
erdafitinib (Balversa; Astex -> Janssen)
darolutamide (Nubeqa; Orion -> Bayer)
fedratinib (Inrebic; TargeGen -> Sanofi -> Celgene)
selinexor (Xpovio; Karyopharm Therapeutics)
entrectinib (Rozlytrek; Roche)

2018

glasdegib (Daurismo; Pfizer)